InvestorsObserver
×
News Home

Should You Buy CymaBay Therapeutics Inc (CBAY) Stock?

Thursday, October 01, 2020 10:44 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy CymaBay Therapeutics Inc (CBAY) Stock?

CymaBay Therapeutics Inc (CBAY) stock is up 45.01% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CBAY stock a score of 83 out of a possible 100.

That rank is influenced by a long-term technical score of 97. CBAY's rank also includes a short-term technical score of 80. The fundamental score for CBAY is 72. In addition to the average rating from Wall Street analysts, CBAY stock has a mean target price of 12.06. This means analysts expect the stock to add 62.75% over the next 12 months.

Overall Score - 83
CBAY has an Overall Score of 83. Find out what this means to you and get the rest of the rankings on CBAY!

What's Happening with CBAY Stock Today

CymaBay Therapeutics Inc (CBAY) stock has risen 2.32% while the S&P 500 is up 0.14% as of 10:42 AM on Thursday, Oct 1. CBAY is up $0.17 from the previous closing price of $7.24 on volume of 1,197,179 shares. Over the past year the S&P 500 has risen 16.63% while CBAY is up 45.01%. CBAY lost -$1.16 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on CymaBay Therapeutics Inc (CBAY) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App